Search

Filters
Clear All
  • 17
  • 51
  • 630

Phase

  • 12
  • 14
  • 55
  • 8
  • 75
  • 5
  • 520
  • 619
  • 278
  • 684
  • 14

Found 698 in-health trials

A listing of in-health medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

N
Nabil Adra, MD
18 years - 100 years
Male
Phase 2/3
This study investigates the treatment of PSMA-positive metastatic castration-resistant prostate cancer (mCRPC) using an investigational medication called AAA817. The purpose of this study is to compare the effects of AAA817 with the standard of care treatment in adults who have already been treated with certain cancer therapies but have not …
M
Malaz Boustani, MD
65 years - 100 years
All genders
Interventional
This study investigates the use of Smart Virtual Reminiscence (SVR) therapy for older adults with Alzheimer's Disease and Related Dementias (ADRD). ADRD can cause changes in behavior and mood, known as Behavioral and Psychological Symptoms of Dementia (BPSD), like agitation or depression. The SVR therapy is a computer program that …
T
Tareq Salous
18 years - 100 years
All genders
Phase 3
This study investigates how well an investigational medication combination works in treating adults with untreated locally advanced or metastatic urothelial carcinoma with an FGFR3 genetic alteration. Urothelial carcinoma is a type of cancer that occurs in the urinary system. This study uses a combination of medications, including monoclonal antibodies, which …
G
Gregory Sokol, MD
20 years or below
Accepts healthy volunteer
All genders
The study investigators are interested in learning more about how drugs, that are given tohildren by their health care provider, act in the bodies of children and young adults in hopes to find the most safe and effective dose for children. The primary objective of thisudy is to evaluate the …
G
Greg Durm, MD
18 years - 100 years
All genders
Phase 2
Interventional
The purpose of this study is to compare two treatment approaches that are currently used after surgery for head and neck cancer. One approach is to administer radiation therapy alone. A second approach is to administer radiation therapy along with the chemotherapy drug, cisplatin.
M
Monika Fischer, MD
18 years - 65 years
All genders
Phase 3
Interventional
What is the purpose of this study?The main aim of this study is to learn whether vedolizumab and upadacitinib given together (also called dual targeted therapy or DTT) reduces bowel inflammation and ulcers in the bowel compared to vedolizumab only (also called monotherapy) in adults with moderately or severely active …
R
Raj Vuppalanchi, MD
18 years - 80 years
All genders
Phase 3
Interventional
This study investigates the effects of an investigational medication on people with non-cirrhotic NASH (Nonalcoholic Steatohepatitis) or MASH (Metabolic Dysfunction-Associated Steatohepatitis) and fibrosis. NASH and MASH are conditions where fat builds up in the liver, causing inflammation and damage. The purpose of this study is to see if the investigational …
J
Julie Clary, MD
18 years - 100 years
All genders
Phase 3
Interventional
This study investigates the effect of an investigational medication on reducing major adverse cardiovascular events in adults with high levels of lipoprotein(a), a substance in the blood linked to heart disease. People with high lipoprotein(a) may have had a heart attack, stroke, or other heart-related issues, or be at risk …
J
Jennifer King
18 years or above
All genders
Phase 2
Interventional
What is the purpose of this study?Subjects with cT2-T3N0M0 urothelial cancer of the bladder will be enrolled. After completingwo cycles of pembrolizumab, subjects will undergo a restaging MRI of the abdomen and pelvis with a standard acquisition protocol (as outlined in the protocol) as well as CT chest. A CThe …
R
Rohan Maniar
18 years - 100 years
All genders
Phase 2
What is the purpose of this study?This phase II Expanded Lung-MAP treatment trial tests how well amivantamab-subcutaneous (SC) works in treating patients patients with MET amplification non-small cell lung cancer. Amivantamab-SC is a drug that reduces extra copies of the MET gene, a change present in your tumor. Giving amivantamab-SC …
681 - 690 of 698